SCHEMBL4661287

SCHEMBL4661287

CCCCCCC1=CCCC=C1c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 2/20 0.40
PTPN1 P18031 1/20 0.40
GPR84 Q9NQS5 1/20 0.40
DHFR P00374 1/20 0.39
CNR2 P34972 1/20 0.39
GAA P10253 1/20 0.39
HTT P42858 1/20 0.39
HSD11B1 P28845 1/20 0.39
KCNH2 Q12809 2/20 0.38
LIPG Q9Y5X9 1/20 0.38
MAPT P10636 1/20 0.37
TSHR P16473 1/20 0.37
HTR2A P28223 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4659945 0.98 GPR84 (0.41) CNR1PTPN1GPR84DHFRCNR2
SCHEMBL4662723 0.93 TSHR (0.39) CNR1PTPN1GPR84CNR2GAA
SCHEMBL13974896 0.71 PTPN1 (0.55) CNR1PTPN1GPR84HSD11B1
Biphenyl SCHEMBL27342649 0.71 ALDH1A1 (0.53) GPR84HTTMAPTTSHR
Biphenyl SCHEMBL5868587 0.71 ALDH1A1 (0.53) GPR84HTTMAPTTSHR
Hexadecane SCHEMBL8524813 0.71 ALDH1A1 (0.53) GPR84HTTMAPTTSHR
Biphenyl SCHEMBL27853080 0.71 ALDH1A1 (0.53) GPR84HTTMAPTTSHR
Dodecane SCHEMBL27916009 0.71 ALDH1A1 (0.53) GPR84HTTMAPTTSHR
SCHEMBL28111153 0.69 GCGR (0.58) GPR84DHFRHSD11B1KCNH2LIPG
Biphenyl SCHEMBL15347228 0.69 ALDH1A1 (0.56) GPR84GAAHTTHSD11B1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1919907-A2 HETEROCYCLIC COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-05-14 EP disclosed
WO-2007026959-A2 DERIVATIVES OF 4-PIPERAZIN-1-YL-4-BENZ0 [B] THIOPHENE SUITABLE FOR THE TREATMENT OF CNS DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-03-08 WO disclosed